Monday - June 22, 2026

Category Archives: Science

Spinal Muscular Atrophy Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Spinal Muscular Atrophy Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Spinal Muscular Atrophy pipeline landscape. It covers the Spinal Muscular Atrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Soft Tissue Sarcoma Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Soft Tissue Sarcoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It covers the Soft Tissue Sarcoma Marketed and Pipeline Drugs profiles, including clinical and nonclinical stage … Continue reading →

GLP-1 Agonists Market Size to Surpass USD 114.5 Billion by 2036, Driven by Expanding Indications, Rising Obesity Burden, and Next-Generation Incretin Therapies | DelveInsight

The GLP-1 Agonists Market is expected to witness remarkable growth through 2036, fueled by the increasing prevalence of obesity and type 2 diabetes, expanding regulatory approvals across multiple indications, favorable clinical outcomes, and the anticipated launch of innovative next-generation therapies. … Continue reading →

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia Market is Projected to Witness Significant Growth by 2036 Driven by Rising Antimicrobial Resistance and Emerging Antibiotic Therapies

The Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Market is expected to grow significantly through 2036, driven by the rising prevalence of multidrug-resistant bacterial infections, increasing ICU-acquired infections, and higher hospitalization rates. The anticipated launch of emerging therapies such as BV-100 … Continue reading →

Chronic Kidney Disease Market Expected to Witness Significant Growth Through 2036, Driven by Novel Therapies, Rising Disease Burden, and Expanding Treatment Landscape | DelveInsight

The Chronic Kidney Disease market is poised for substantial growth across the 7MM during the forecast period (2026–2036), driven by increasing disease prevalence, growing incidence of diabetes and hypertension, advancements in diagnostic technologies, and the anticipated launch of innovative therapies … Continue reading →

TIGIT Inhibitors Market is Expected to Transform Cancer Immunotherapy by 2036, Driven by Expanding Oncology Applications and Emerging Next-Generation Checkpoint Inhibitors | DelveInsight

The TIGIT Inhibitors Market is poised for substantial growth through 2036, fueled by increasing investments in cancer immunotherapy, expanding clinical applications across multiple solid tumors and hematological malignancies, and the anticipated launch of novel anti-TIGIT therapies. Emerging TIGIT inhibitors such … Continue reading →

Nephrotic Syndrome Pipeline Expands as 3+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Nephrotic Syndrome Pipeline Insight 2026” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Nephrotic Syndrome pipeline landscape. It covers the Nephrotic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Acute Respiratory Distress Syndrome Pipeline Expands as 50+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Acute Respiratory Distress Syndrome Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers the Acute Respiratory Distress Syndrome pipeline drug profiles, including clinical and nonclinical … Continue reading →